1. Home
  2. VECO vs GLPG Comparison

VECO vs GLPG Comparison

Compare VECO & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veeco Instruments Inc.

VECO

Veeco Instruments Inc.

HOLD

Current Price

$30.90

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$31.11

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VECO
GLPG
Founded
1945
1999
Country
United States
Belgium
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
VECO
GLPG
Price
$30.90
$31.11
Analyst Decision
Buy
Hold
Analyst Count
6
4
Target Price
$28.00
$31.33
AVG Volume (30 Days)
632.4K
102.2K
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.83
N/A
Revenue
$681,408,000.00
$336,643,201.00
Revenue This Year
N/A
$3.61
Revenue Next Year
$9.81
N/A
P/E Ratio
$36.86
N/A
Revenue Growth
N/A
10.31
52 Week Low
$16.92
$22.36
52 Week High
$34.45
$37.78

Technical Indicators

Market Signals
Indicator
VECO
GLPG
Relative Strength Index (RSI) 54.95 45.01
Support Level $31.49 $31.41
Resistance Level $33.41 $32.75
Average True Range (ATR) 1.12 0.52
MACD 0.12 0.08
Stochastic Oscillator 53.69 11.32

Price Performance

Historical Comparison
VECO
GLPG

About VECO Veeco Instruments Inc.

Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The majority of the company's revenue is generated from sales to the Semiconductor Industry and within China.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: